Prograf 5 mg Hartkapseln

DRUG3 trials

Sponsors

F. Hoffmann-La Roche AG, Universitaetsklinikum Schleswig-Holstein AöR, Universitaetsklinikum Essen AöR

Conditions

Caucasian paediatric kidney transplant recipientsICD 10: Z94.4 Liver transplant statusPrimary Membranous Nephropathy (pMN)

Phase 2

A multi-center interventional study to assess pharmacokinetics, effectiveness and tolerability of prolonged-release Tacrolimus after Paediatric Kidney Transplantation (Pro-Tac)

CompletedCTIS2024-516608-40-00

Universitaetsklinikum Essen AöRCaucasian paediatric kidney transplant recipients

Start: 2022-02-23End: 2026-01-08Target: 30Updated: 2026-01-06

Phase 3

A Phase III, Randomized, Open-Label Active Comparator-Controlled Multicenter Study to Evaluate Efficacy and Safety of Obinutuzumab in Patients with Primary Membranous Nephropathy

Active, not recruitingCTIS2023-506525-11-00

F. Hoffmann-La Roche AGPrimary Membranous Nephropathy (pMN)

Start: 2021-04-19Target: 52Updated: 2025-02-03

Phase 4

Cognitive function after liver transplantation comparing Tacrolimus formulations

Active, not recruitingCTIS2024-513963-22-00

Universitaetsklinikum Schleswig-Holstein AöRICD 10: Z94.4 Liver transplant status

Start: 2020-12-09Target: 150Updated: 2025-05-19